Chronic Lymphocytic Leukemia Clinical Trial

Characterization of Proliferating Compartment in B-Cell Patients and in Healthy Aging Subjects

Summary

By ingesting a non-radioactive and non-toxic compound "heavy water" for 6 weeks, the DNA of newly developed cells in the body of subjects with B-cell leukemia-cll/" >chronic lymphocytic leukemia can be labeled and followed by performing routine blood draws at specified time intervals. By using mass spectrometric analysis we can measure how quickly new B-CLL cells are generated in the bone marrow and how quickly they leave the blood, a measure of cell turnover. This will help us to better understand the unique characteristics of this disease process.

View Full Description

Full Description

By ingesting a non-radioactive and non-toxic compound "heavy water" for 6 weeks, the DNA of newly developed cells in the body of subjects with B-cell chronic lymphocytic leukemia (B-CLL) can be labeled and followed by performing routine blood draws at specified time intervals. By using mass spectrometric analysis we can measure how quickly new B-CLL cells are generated in the bone marrow and how quickly they leave the blood, a measure of cell turnover. This will help us to better understand the unique characteristics of this disease process.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18 years of age,
Patients must be willing to contribute the required amount of blood without compromising their well being,
Participants must be willing to be contacted in the future.

Exclusion Criteria:

Pregnancy,
Patients who are known to be anemic, with a hemoglobin < 8,
Patients who are known to be infected with HIV.

Study is for people with:

Chronic Lymphocytic Leukemia

Estimated Enrollment:

90

Study ID:

NCT01110863

Recruitment Status:

Completed

Sponsor:

Northwell Health

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Feinstein Institute for Medical Research
Manhasset New York, 11030, United States

How clear is this clinincal trial information?

Study is for people with:

Chronic Lymphocytic Leukemia

Estimated Enrollment:

90

Study ID:

NCT01110863

Recruitment Status:

Completed

Sponsor:


Northwell Health

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider